Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this
is the 4th gastric cancer guideline published in Korea which is the revised version of …

Gastric cancer is one of the leading causes of cancer-related death worldwide. Many
patients have inoperable disease at diagnosis or have recurrent disease after resection with …

Background Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-
oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the …

Gastric cancers, with gastric adenocarcinoma (GAC) as the most common histological type,
impose a considerable global health burden. Although the screening strategies for early …

Gastric cancer is a major source of global cancer mortality with limited treatment options and
poor patient survival. As our molecular understanding of gastric cancer improves, we are …

Background The optimum curative approach to adenocarcinoma of the oesophagus and
oesophagogastric junction is unknown. We aimed to compare trimodality therapy …

Background Neoadjuvant therapy improves long-term survival after oesophagectomy,
treating oesophageal cancer, but the evidence to date is insufficient to determine which of …

Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary
approach. Extensive treatment might be associated with a considerable decline in health …

Objective: The aim of the study was to determine the optimal extent of lymph node dissection
for the 2 histological types of esophagogastric junction (EGJ) tumors based on the incidence …

Background: Despite its decreasing incidence, gastric cancer (GC) remains one of the
leading cancers in the world and an important global healthcare problem due to its overall …